DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Sledge jr. GW, Toi M, Neven P. et al.
MONARCH 2: abemaciclib in combination with fulvestrant in patients with HR+/HER2- advanced breast cancer who progressed on endocrine therapy.
J Clin Oncol 2017;
35 (Suppl.) Abstr. 1000
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.